Search
DarioHealth Corp
DRIOAdd to Watchlist
7.280USD
+0.570+8.49%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
53.14MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+8.49%
5 Days
+3.56%
1 Month
-4.21%
6 Months
-30.80%
Year to Date
-36.03%
1 Year
-48.35%
Key Figures
6.895Open
8.000High
61.00KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.84%Turnover Ratio
6.750Prev. Close
6.895Low
333.82KTurnover
LossP/E Static
0.85P/B
0.00%Div Yield TTM
-37.22%ROA
17.74452wk High
3.84Volume Ratio
-40.98MNet Profit
7.30MShares
-13.8842EPS TTM
1.10Beta
-92.87%ROE
5.93552wk Low
16.37%Amplitude
57.31%Gross Margin
53.14MMarket Cap
-1.69Reward/Risk
6.62%Risk Rate
TradingKey Stock Score of DarioHealth Corp
Currency: USD Updated: 2026-07-02Key Insights
DarioHealth Corp's fundamentals are relatively healthy, and its growth potential is good.Its valuation is considered fairly valued, ranking 105 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 18.50.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
DarioHealth Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
DarioHealth Corp Highlights
StrengthsRisks
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Growing
The company is in a growing phase, with the latest annual income totaling USD 22.36M.
Overvalued
The company’s latest PE is -0.52, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 782.90K shares, decreasing 22.05% quarter-over-quarter.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
18.500
Target Price
+174.07%
Upside Space
DarioHealth Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
DarioHealth Corp Info
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Ticker SymbolDRIO
CompanyDarioHealth Corp
CEORaphael (Erez)
Websitehttps://shop.mydario.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of DarioHealth Corp (DRIO)?
The current price of DarioHealth Corp (DRIO) is 7.28.
What is the symbol of DarioHealth Corp?
The ticker symbol of DarioHealth Corp is DRIO.
What is the 52-week high of DarioHealth Corp?
The 52-week high of DarioHealth Corp is 17.74.
What is the 52-week low of DarioHealth Corp?
The 52-week low of DarioHealth Corp is 5.93.
What is the market capitalization of DarioHealth Corp?
The market capitalization of DarioHealth Corp is 53.14M.
Is DarioHealth Corp (DRIO) currently rated as Buy, Hold, or Sell?
According to analysts, DarioHealth Corp (DRIO) has an overall rating of Buy, with a price target of 18.50.
What is the Earnings Per Share (EPS TTM) of DarioHealth Corp (DRIO)?
The Earnings Per Share (EPS TTM) of DarioHealth Corp (DRIO) is -15.50.